Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 53
Filter
1.
Transplant Proc ; 52(10): 3044-3050, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32571706

ABSTRACT

INTRODUCTION: Despite great improvements in the short-term patient and kidney graft survival, the long-term morbidity and mortality in kidney transplant recipients still remains a significant problem. The aim of the study was to evaluate the impact of both donor and transplant recipient factors, as well as renal function indices on the very long-term (>25 years) kidney allograft survival. MATERIAL AND METHODS: Retrospective analysis was performed on the data of 41 kidney transplant recipients (KTR), group A: follow-up = 25 years, 20 KTR, 10 male, mean age (mean [M] ± standard deviation [SD]): 34.6 ± 12.6 years, 14 living donors (LD), 6 cadaveric donors (CD); group B: follow-up > 25 years, 21 KTR, 16 male, mean age (M ± SD): 30.86 ± 12.37 years, 14 LD, 7 CD). Kidney graft origin, post-kidney transplantation diabetes mellitus, HLA compatibility, delayed graft function, and acute rejection episodes were also analyzed retrospectively. Statistical analysis with Mann-Whitney test and Kaplan-Meier survival analysis was performed (SPSS 20.0 for Windows). RESULTS: The mean age of CDs was lower than that of LDs: CD mean age (M ± SD): 23.84 ± 16.26 years vs LD mean age: 52.75 ± 12.42 years (P < .001). Cadaveric kidney graft was associated with better renal allograft function 10, 15, and 25 years post kidney transplant. None of the other factors analyzed reached statistical significance between the 2 groups. CONCLUSION: The age of the donor and the kidney graft origin are important co-factors of the very long-term kidney allograft survival.


Subject(s)
Kidney Transplantation/mortality , Survivors/statistics & numerical data , Tissue Donors/statistics & numerical data , Adult , Aged , Allografts , Cross-Sectional Studies , Female , Graft Survival , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Retrospective Studies
2.
Hippokratia ; 24(2): 91-93, 2020.
Article in English | MEDLINE | ID: mdl-33488059

ABSTRACT

BACKGROUND: Retropharyngeal space lipomas (RSL) are rare benign tumors of the head and neck region. They can, sporadically, occur as part of syndromic lipomatosis, such as Madelung disease. Symptoms are caused due to increasing pressure on surrounding structures. Description of case: We present a 64-year-old male patient with symptomatic RSL and symmetric lipomatosis, who was treated surgically. CONCLUSION: RSL can grow to a large size before becoming symptomatic. Their diagnosis and treatment can be challenging due to their anatomical site, diverse symptomatology, and diffuse growth pattern. Imaging is necessary for diagnosis. In the vast majority of cases, RSLs are treated surgically with a favorable outcome. HIPPOKRATIA 2020, 24(2): 91-93.

3.
Transplant Proc ; 51(2): 416-420, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30879555

ABSTRACT

AIMS: Variations of the anatomy of donor hepatic arteries increase the number of arterial anastomoses during liver transplantation and, possibly, the incidence of hepatic artery thrombosis (HAT). In this study, we describe the arterial anatomic variations in liver grafts procured and transplanted by a single center in Greece, the techniques of arterial anastomosis, and their effect on the incidence of early HAT. MATERIALS AND METHODS: From January 2013 to December 2017, the arterial anatomy of 116 grafts procured for liver transplantation were recorded, as well as the technique of arterial anastomosis and the incidence of early hepatic artery thrombosis (HAT <30 days). RESULTS: A single hepatic artery was recorded in 72.41% of the procured grafts, an aberrant left hepatic artery (accessory or replaced) in 18 grafts (15.52%), and an aberrant right hepatic artery (accessory or replaced) in 17 grafts (14.66%), while other variations were observed in less than 1% of the procured livers. Of the 116 primary liver transplantations, 6 patients (5.17%) developed early HAT <30 days. Two of these patients (1.72%) had 1 anastomosis of the hepatic artery and 4 (3.45%) had 2 anastomoses due to anatomic variations. CONCLUSIONS: Anatomic variations of the hepatic artery in liver grafts is a common finding and increase the incidence of early HAT but not to a degree to make these grafts unusable.


Subject(s)
Hepatic Artery/abnormalities , Hepatic Artery/surgery , Liver Transplantation/methods , Thrombosis/epidemiology , Thrombosis/etiology , Adult , Anastomosis, Surgical/methods , Anatomic Variation , Female , Greece , Humans , Incidence , Liver Diseases/epidemiology , Liver Diseases/etiology , Male , Middle Aged , Vascular Surgical Procedures/methods
4.
Transplant Proc ; 51(2): 457-460, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30879566

ABSTRACT

INTRODUCTION: The importance of preoperative donor/recipient colonization or donor infection by extensively drug-resistant Gram-negative bacteria (XDR-GNB) and its relation to serious post-transplantation infection pathogenicity in liver transplantation (LT) patients has not been clarified. AIM: Prevention of postoperative infection due to XDR-GNB with the appropriate perioperative chemoprophylaxis or treatment based on preoperative donor/recipient surveillance cultures in LT patients, as well as their outcome. MATERIALS AND METHOD: Twenty-six patients (20 male, 6 female) were studied (average preoperative Model for End-Stage Liver Disease score ≈15, range: 8-29) from January 2017 to January 2018. In all patients, blood, urine, and bronchial secretions culture samples as well as a rectal colonization culture were taken pre- and postoperatively, once weekly after LT, and after intensive care unit discharge. Recipients with positive XDR-GNB colonization and patients receiving a transplant from a donor with an XDR-GNB positive culture or colonization received the appropriate chemoprophylaxis one half hour preoperatively according to culture results. De-escalation of the antibiotic regimen was done in 2 to 5 days based on the colonization/culture results of the donor and recipient and their clinical condition. Evaluation for serious infection was done at 1 week and at 28 days for outcome results. RESULTS: Fourteen out of 26 recipients (53.8%) were positive for XDR-GNB colonization preoperative, with 2/14 (14.28%) presenting serious infection due to the same pathogen. Intensive care unit length of stay was significantly longer in colonized with XDR-GNB patients (P < .0001). The outcome of colonized patients was 6/14 (42.8%) expired, but only in 2/14 (14.2%) was mortality attributable to infection. CONCLUSION: Administering appropriate perioperative chemoprophylaxis and treatment may limit the frequency of XDR-GNB infections and intensive care unit length of stay and may improve the outcome in LT recipients.


Subject(s)
Antibiotic Prophylaxis/methods , Gram-Negative Bacterial Infections/immunology , Gram-Negative Bacterial Infections/prevention & control , Immunocompromised Host , Liver Transplantation , Adult , Anti-Bacterial Agents/therapeutic use , Female , Gram-Negative Bacteria , Humans , Male , Middle Aged , Prospective Studies , Tissue Donors
5.
Transpl Infect Dis ; 18(5): 667-673, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27421122

ABSTRACT

BACKGROUND/AIMS: Nucleos(t)ide analogs (NAs) have made a hepatitis B immunoglobulin (HBIG)-sparing protocol an attractive approach against hepatitis B virus (HBV) recurrence after liver transplantation (LT). However, this approach is considered controversial in patients transplanted for HBV and hepatitis D (HDV) co-infection. MATERIAL/METHODS: All patients transplanted for HBV/HDV cirrhosis were evaluated. After LT, each patient received HBIG + NAs and then continued with NAs prophylaxis. All patients were followed up with HBV serum markers and HBV DNA, while anti-HDV/HDV RNA was performed in those with HBV recurrence. RESULTS: A total of 34 recipients were included (22 men, age: 46.7 ± 16 years). After HBIG discontinuation, NAs were received as monoprophylaxis (lamivudine [LAM]: 2, adefovir [AFV]: 1, entecavir: 9, tenofovir [TDF]: 12) or dual prophylaxis (LAM + AFV [or TDF]: 10 patients). Two (5.8%) of the 34 patients had HBV/HDV recurrence after HBIG withdrawal (median follow-up: 28 [range, 12-58] months). These 2 patients had undetectable HBV DNA at LT. Statistical analysis revealed that those with recurrence had received HBIG for shorter period, compared to those without recurrence (median: 9 vs. 28 months, P = 0.008). CONCLUSIONS: We showed for the first time, to our knowledge, that maintenance therapy with NAs prophylaxis after HBIG discontinuation was effective against HBV/HDV recurrence, but it seems that a longer period of HBIG administration might be needed before it is withdrawn after LT.


Subject(s)
Antiviral Agents/therapeutic use , Coinfection/prevention & control , Hepatitis B, Chronic/prevention & control , Hepatitis D, Chronic/prevention & control , Immunoglobulins/therapeutic use , Liver Cirrhosis/therapy , Liver Transplantation , Secondary Prevention/methods , Adenine/administration & dosage , Adenine/adverse effects , Adenine/analogs & derivatives , Adenine/therapeutic use , Adult , Antiviral Agents/administration & dosage , Antiviral Agents/adverse effects , Coinfection/complications , DNA, Viral/isolation & purification , Drug Therapy, Combination , Female , Guanine/administration & dosage , Guanine/adverse effects , Guanine/analogs & derivatives , Guanine/therapeutic use , Hepatitis B virus/isolation & purification , Hepatitis B, Chronic/complications , Hepatitis D, Chronic/complications , Humans , Immunoglobulins/administration & dosage , Lamivudine/administration & dosage , Lamivudine/adverse effects , Lamivudine/therapeutic use , Liver Cirrhosis/drug therapy , Liver Cirrhosis/surgery , Male , Middle Aged , Organophosphonates/administration & dosage , Organophosphonates/adverse effects , Organophosphonates/therapeutic use , Tenofovir/administration & dosage , Tenofovir/adverse effects , Tenofovir/therapeutic use , Treatment Outcome , Withholding Treatment , Young Adult
6.
Hippokratia ; 19(3): 249-55, 2015.
Article in English | MEDLINE | ID: mdl-27418785

ABSTRACT

BACKGROUND: Liver regeneration is vital for the survival of patients submitted to extensive liver resection as a treatment of hepatocellular carcinoma (HCC). Sorafenib is a multikinase inhibitor of angiogenesis and cell division, both of which are integral components of liver regeneration. We investigated the effect of preoperative treatment with sorafenib, a drug used for the treatment of HCC, on liver regeneration and angiogenesis in healthy rats, after two-thirds partial hepatectomy (PH2/3). METHODS: In total 48 Wistar rats received intragastric injections of sorafenib (30 mg/kg/d) or vehicle, underwent PH2/3, and were sacrificed at 48, 96 or 168 hours after that. The regenerative index of the liver remnant was studied, as well as the mitotic index. DNA synthesis and angiogenesis were estimated by immunohistochemistry for the Ki-67 and CD34 antigens, respectively. RESULTS: Sorafenib reduced significantly the regenerative index at all time points but not the mitotic index at 48, 96 or 168 hours. Deoxyribonucleic acid (DNA) synthesis and angiogenesis were not affected significantly either. CONCLUSIONS: Sorafenib, when administered preoperatively, reduces incompletely and transiently the regeneration of the liver after PH2/3 in rats. This could mean that sorafenib can be used as neoadjuvant treatment of patients with HCC prior to liver resection, but further experimental and clinical studies are needed to establish the safety of this treatment. Hippokratia 2015; 19 (3): 249-255.

7.
J Viral Hepat ; 22(7): 574-80, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25385239

ABSTRACT

Recent studies showed that telbivudine in patients with hepatitis B virus (HBV) infection improved their glomerular filtration rate (GFR), but data regarding its impact on renal function in liver transplant (LT) recipients are very limited. We evaluated 17 consecutive recipients who received at baseline nucleos(t)ide analogue(s) (NAs) other than telbivudine for 12 months, and then they were switched to telbivudine prophylaxis for another 12 months. In each patient, laboratory data including evaluation of GFR (using MDRD and CKD-EPI) were prospectively recorded. The changes in GFR (ΔGFR) between baseline and after 12 months (1st period) and between telbivudine initiation and 24 months (2nd period) were evaluated. All patients remained serum HBsAg and HBV-DNA negative. GFR-MDRD at baseline, 12 months and 24 months were 72 ± 18, 67.8 ± 16 and 70.3 ± 12 mL/min, respectively, (P = 0.025 for comparison between 12 months and 24 months). ΔGFR at the 1st period was significantly lower, compared with ΔGFR at the 2nd period [mean ΔGFR-MDRD: -4.2 (range: -24-9) vs 2.5 (range: -7-22) mL/min, P = 0.013; mean ΔGFR-CKD-EPI: -4.2 (range: -19-10) vs 4.0 (range: -7-23) mL/min, P = 0.004], although the serum levels of calcineurin inhibitors were similar between the two periods. A second group of recipients (n = 17) who remained under the same nontelbivudine NA(s) for 24 months had a decline in the mean eGFR during the total follow-up period. In conclusion, we showed that telbivudine administration in LT recipients for HBV cirrhosis was effective and it was associated with significant improvement in renal function, but this remains to be confirmed in larger well-designed studies.


Subject(s)
Antiviral Agents/adverse effects , Chemoprevention/adverse effects , Glomerular Filtration Rate/drug effects , Hepatitis B, Chronic/prevention & control , Kidney/drug effects , Liver Transplantation , Thymidine/analogs & derivatives , Adult , Aged , Antiviral Agents/therapeutic use , Chemoprevention/methods , DNA, Viral/blood , Female , Hepatitis B Surface Antigens/blood , Hepatitis B, Chronic/complications , Humans , Kidney/physiology , Kidney Function Tests , Liver Cirrhosis/surgery , Male , Middle Aged , Prospective Studies , Telbivudine , Thymidine/adverse effects , Thymidine/therapeutic use , Young Adult
8.
Transplant Proc ; 46(9): 3216-8, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25420863

ABSTRACT

BACKGROUND: Carbapenem-resistant Klebsiella pneumoniae (CRKP) has emerged as an important cause of bloodstream infections in intensive care units (ICUs). The aim of this study was to determine risk factors for bloodstream infections caused by CRKP as well as risk factors for CRKP-associated mortality among ICU patients after orthotopic liver transplantation (LT). METHODS: The study cohort of this observational study comprised 17 ICU patients after LT with CRKP bloodstream infections. The data from these patients were matched with 34 ICU patients (1:2) after LT without CRKP infections. The 2 groups were compared to identify risk factors for development of CRKP infection and risk factors for mortality. RESULTS: Seventeen CRKP bloodstream infections occurred in ICU patients after LT from January 1, 2008, to December 31, 2011. In univariate analysis, primary liver disease and especially hepatitis C virus infection or hepatocellular cancer were significant factors for development of CRKP. Acute Physiology and Chronic Health Evaluation (APACHE II) score and Sequential Organ Failure Assessment (SOFA) score as well as CRKP bloodstream infection were predictors for ICU death (P < .05) in univariate analysis. CONCLUSIONS: CRKP bloodstream infections affect immunocompromised post-transplantation patients more. Bloodstream infections with CRKP along with APACHE and SOFA scores were predictors of death in ICU patients after LT.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Bacteremia/epidemiology , Bacterial Proteins/biosynthesis , Intensive Care Units , Klebsiella Infections/epidemiology , Klebsiella pneumoniae/enzymology , Liver Transplantation , beta-Lactamases/biosynthesis , Adult , Aged , Bacteremia/drug therapy , Bacteremia/microbiology , Drug Resistance, Bacterial , Female , Follow-Up Studies , Greece/epidemiology , Humans , Incidence , Klebsiella Infections/drug therapy , Klebsiella Infections/microbiology , Klebsiella pneumoniae/isolation & purification , Male , Middle Aged , Postoperative Complications , Retrospective Studies , Risk Factors , Survival Rate/trends
9.
Transplant Proc ; 46(9): 3222-7, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25420865

ABSTRACT

BACKGROUND: Acute renal dysfunction is presented quite often after orthotopic liver transplantation (LT), with a reported incidence of 12-64%. The "RIFLE" criteria were introduced in 2004 for the definition of acute kidney injury (AKI) in critically ill patients, and a revised definition was proposed in 2007 by the Acute Kidney Injury Network (AKIN), introducing the AKIN criteria. The aim of this study was to record the incidence of AKI in patients after LT by both classifications and to evaluate their prognostic value on mortality. METHODS: We retrospectively evaluated the records of patients with LT over 2 years (2011-2012) and recorded the incidence of AKI as defined by the RIFLE and AKIN criteria. Preoperative and admission severity of disease scores, duration of mechanical ventilation, intensive care unit length of stay, and 30- and 180-day survivals were also recorded. RESULTS: Seventy-one patients were included, with an average age of 51.78 ± 10.3 years. The incidence of AKI according to the RIFLE criteria was 39.43% (Risk, 12.7%; Injury, 12.7%; Failure, 14.1%), whereas according to the AKIN criteria it was 52.1% (stage I, 22.5%; stage II, 7%; stage II 22.55%). AKI, regardless of the classification used, was related to the Model for End-Stage Liver Disease score, the volume of transfusions, the duration of mechanical ventilation, and survival. The presence of AKI was related to higher mortality, which rose proportionally with the severity of AKI as defined by the stages of either the RIFLE or the AKIN criteria. CONCLUSIONS: AKI classifications according to the RIFLE and AKIN criteria are useful tools in the recognition and classification of the severity of renal dysfunction in patients after LT, because they are associated with higher mortality, which rises proportionally with the severity of renal disease.


Subject(s)
Acute Kidney Injury/classification , Liver Transplantation/adverse effects , Postoperative Complications/classification , Acute Kidney Injury/diagnosis , Acute Kidney Injury/epidemiology , End Stage Liver Disease/surgery , Female , Follow-Up Studies , Greece/epidemiology , Humans , Incidence , Male , Middle Aged , Postoperative Complications/diagnosis , Postoperative Complications/epidemiology , Prognosis , Retrospective Studies , Severity of Illness Index
10.
Transplant Proc ; 46(9): 3219-21, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25420864

ABSTRACT

BACKGROUND: This 3-year prospective, observational, single-center study was undertaken to describe prescription, microbiology findings, tolerance, and efficacy of tigecycline for carbapenem-resistant Klebsiella pneumoniae (CRKP) infections after liver transplantation in the intensive care unit (ICU). METHODS: All patients after liver transplantation treated with tigecycline for ≥3 days for CRKP infections in our ICU from January 1, 2010, to December 31, 2012, were studied. Patient characteristics, indication of treatment, bacteriology, and ICU mortality were collected. The main end points were clinical and microbiologic efficacy and tolerance of tigecycline. RESULTS: Over the study period, 8 men and 2 women (18 CRKP isolates), aged 54.3 ± 7.7 years, were included in the study. Acute Physiology and Chronic Health Evaluation and Sequential Organ Failure Assessment scores on ICU admission were 13.7 ± 2.7 and 10 ± 2.2, respectively. In 7 isolates, tigecycline was prescribed for CRKP blood stream infection (BSI), in 6 for complicated intra-abdominal infection (IAI), in 2 for ventilator-associated pneumonia (VAP), in 2 for surgical site infection, and in 1 for urinary tract infection. In 4 cases, tigecycline was prescribed for secondary BSI followed by VAP and/or IAI. All isolates were susceptible to tigecycline, 83.4% to colistin, 44.5% to gentamicin, and 27.8% to amikacin. In 2 patients, tigecycline was prescribed as monotherapy. Three patients had clinical failure. The microbiologic response rate was 70%. Superinfection was detected in 5 patients, and Pseudomonas aeruginosa was the most frequently isolated pathogen. Tigecycline was generally well tolerated. The ICU mortality rate was 60% with attributable mortality rate 30%. CONCLUSIONS: Our pilot study suggests that tigecycline shows a good safety and tolerance profile in patients with CRKP infections in the ICU after orthotopic liver transplantation. Limited therapeutic options for such infections leave physicians no choice but to use tigecycline for off-label indications such as urinary tract and blood stream infections.


Subject(s)
Carbapenems/pharmacology , Intensive Care Units , Klebsiella Infections/drug therapy , Klebsiella pneumoniae/drug effects , Liver Transplantation , Minocycline/analogs & derivatives , beta-Lactam Resistance , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Female , Follow-Up Studies , Greece/epidemiology , Humans , Incidence , Klebsiella Infections/epidemiology , Klebsiella Infections/microbiology , Klebsiella pneumoniae/isolation & purification , Male , Middle Aged , Minocycline/therapeutic use , Pilot Projects , Prospective Studies , Risk Factors , Tigecycline , Time Factors , Treatment Outcome
11.
B-ENT ; 10(1): 15-20, 2014.
Article in English | MEDLINE | ID: mdl-24765824

ABSTRACT

OBJECTIVES: Peritonsillar abscess (PTA) is a common complication of tonsillitis, yet there is limited consensus regarding its management and epidemiology. Current issues include pre-hospital care provided by general practitioners (GP) in the community (ii) the lack of standardized protocols for in-patient management and (iii) the role of routine microbiology studies in patients with PTA. We performed a retrospective review of confirmed cases of PTA presenting to a west of Ireland tertiary referral center to evaluate the peri-hospital management and role of microbiology studies in such cases. METHODOLOGY: Retrospective chart review of 200 confirmed cases of peritonsillar abscess. RESULTS: The annual incidence of PTA in the west of Ireland population was 14/100,000. Pre-hospital treatment given by Primary Care Physicians (PCP) was often deficient with 84 (42%) patients receiving no treatment prior to hospital referral. Needle aspiration was the most common technique used to drain the PTA 142 (71%). Anaerobes were isolated in 54 (27%) of cases demonstrating an increasing importance of these bacteria in PTA disease. Metronidazole with either benzylpenicillin 72 (36%), or co-amoxiclav 82 (41%), was the most common empiric antibiotics used. Successful treatment of all cases of PTA with the use of empiric antibiotics was achieved before results arising from microbiology became available. CONCLUSION: The epidemiology of PTA is not well described. We have described the epidemiology for PTA disease in the west of Ireland population for the first time. Needle aspiration was the most common drainage technique used. Empiric antibiotic treatment based on clinical response is advised with antibiotics effective against aerobic and anaerobic bacteria recommended.


Subject(s)
Peritonsillar Abscess/microbiology , Peritonsillar Abscess/therapy , Primary Health Care , Adolescent , Adult , Child , Community Health Services , Female , Hospitalization , Humans , Incidence , Ireland/epidemiology , Male , Middle Aged , Peritonsillar Abscess/diagnosis , Practice Patterns, Physicians' , Referral and Consultation , Retrospective Studies , Young Adult
12.
Eur Arch Otorhinolaryngol ; 271(2): 237-43, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23539411

ABSTRACT

Both epistaxis and hypertension are frequent problems in the adult population. The relationship between the level of arterial pressure and incidence of epistaxis in a patient with hypertension is a question that appears frequently in the clinical practice. A systematic review of the literature regarding the relation of arterial hypertension with epistaxis was performed through MEDLINE and EMBASE. All studies, whether examining the correlation of arterial pressure at presentation of a patient with nasal bleeding or the repercussion of episodes of epistaxis in hypertensive patients, were included in this review. Studies were evaluated independently by two reviewers according to a standard evaluation form. Overall, nine studies fulfilled our inclusion criteria. Five of them were single-group (patient) studies, while the remaining four included a control group. In eight studies, the patient group included patients with epistaxis, while one focused on hypertensive patients. Six out of nine studies agree that arterial pressure is higher at the time of epistaxis, as compared to the control group or to the general population. Seven out of nine studies conclude that there is cross-correlation between arterial pressure and the actual incident of epistaxis. The presence of high arterial blood pressure during the actual episode of nasal bleeding cannot establish a causative relationship with epistaxis, because of confounding stress and possible white coat phenomenon, but may lead to initial diagnosis of an already installed arterial hypertension.


Subject(s)
Epistaxis/epidemiology , Hypertension/epidemiology , Epistaxis/physiopathology , Humans , Hypertension/physiopathology , Incidence
13.
Transplant Proc ; 44(9): 2712-4, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23146501

ABSTRACT

AIM: The outcome of simultaneous pancreas-kidney transplantation (SPK) in type 1 diabetes has dramatically improved in recent years. We report the initial results of our SPK program. PATIENTS AND METHODS: From 2008 to 2010, we performed and prospectively obtained data on 4 SPKs in 4 type 1 diabetic patients with chronic renal failure. The recipients were 3 men and 1 woman, of overall mean age of 40.75 ± 4.78 years, mean time from diabetes diagnosis of 27 ± 15 years, and time on dialysis of 3.5 ± 0.57 years. All grafts were procured from multiorgan brain-dead donors of mean age 26 ± 8.16 years and mean body weight of 74 ± 4.34 kg. The pancreatic grafts were transplanted first into the right iliac fossa with mean cold ischemia times of 10.62 ± 3.09 hours for the pancreatic and 14.00 ± 2.97 hours for the renal grafts. Pancreas arterial inflow was re-established by an end-to-side anastomosis of an extension Y-graft to the recipient right iliac artery. The portal vein was sutured to the iliac vein directly. The exocrine secretions of the pancreas were managed by duodenojejunostomy extraperitoneally (n = 3) or intraperitoneally (n = 1). The ureteral anastomosis was performed using the Taguchi technique. RESULTS: After SPK, endocrine pancreatic function was immediately restored in all patients. Insulin administration was stopped within the first 24 hours after surgery. Two patients displayed delayed renal graft function necessitating dialysis for 9 and 23 days, respectively. The postoperative course was prolonged with a mean hospital stay of 82 ± 1 day. At a 31.75 ± 9.03 months follow up all patients are alive with functioning grafts. CONCLUSION: Our experience with SPK, although limited, has shown encouraging results over a short follow-up period.


Subject(s)
Diabetes Mellitus, Type 1/surgery , Diabetic Nephropathies/surgery , Kidney Failure, Chronic/surgery , Kidney Transplantation , Pancreas Transplantation , Adolescent , Adult , Delayed Graft Function/etiology , Delayed Graft Function/therapy , Diabetes Mellitus, Type 1/complications , Diabetic Nephropathies/etiology , Female , Graft Survival , Greece , Humans , Hypoglycemic Agents/therapeutic use , Insulin/therapeutic use , Kidney Failure, Chronic/etiology , Kidney Transplantation/adverse effects , Kidney Transplantation/methods , Length of Stay , Male , Middle Aged , Multidetector Computed Tomography , Pancreas Transplantation/adverse effects , Pancreas Transplantation/methods , Prospective Studies , Renal Dialysis , Time Factors , Treatment Outcome , Young Adult
14.
Transplant Proc ; 44(9): 2715-7, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23146502

ABSTRACT

INTRODUCTION: Renal transplantation is regarded as the optimal treatment for patients with end-stage renal disease. Despite significant improvements in surgical techniques and immunosuppressive therapy, long-term graft survival has not markedly increased over the years, due in part to the occurrence of cytomegalovirus (CMV) infection. PATIENTS AND METHODS: Between January 2001 and September 2011, we performed 592 kidney transplantations (214 living and 378 cadaveric donors). All patients received induction therapy with interleukin (IL)-2 monoclonal antibodies or antithymoglobulin (ATG) combined with calcineurin inhibitors, mycophenolate mofetil, or mTOR antagonists and steroids. All CMV-seronegative patients and all subjects receiving ATG induction were prescribed prophylactic therapy with ganciclovir-intravenous (IV) for 15 days 2.5 mg/kg BW bid and thereafter oral valgancyclovir once a day. CMV infection was diagnosed using a CMV-PVR of ≥ 600 copies. We analyzed the time to manifestations of CMV infection, or positive CMV-PCR, patient and graft survival, serum creatinine (Cr), and blood urea nitrogen (BUN) values before and after CMV infection, as well as type of immunosuppression therapy. RESULTS: The overall incidences of CMV infection and CMV disease were 76/592 (12.8%) and 23/592 (3.9%), respectively. The mean ± standard deviation (SD) times to positive CMV-PCR and CMV disease were 16.66 ± 23.38 months and 106 ± 61.2 (range, 28-215) days, respectively. Mortality was 1% (6/592) among our whole population, 7.9% (6/76) for CMV-infected, and 26% (6/23) in the CMV disease cohort. Cr and BUN showed no significant differences among the groups. CONCLUSIONS: CMV infection and CMV disease comprise significant clinical problems, increasing morbidity and mortality. The use of prophylactic anti-CMV treatment is of paramount importance.


Subject(s)
Cytomegalovirus Infections/epidemiology , Kidney Transplantation/adverse effects , Adult , Aged , Antiviral Agents/administration & dosage , Biomarkers/blood , Blood Urea Nitrogen , Creatinine/blood , Cytomegalovirus/genetics , Cytomegalovirus Infections/diagnosis , Cytomegalovirus Infections/mortality , Cytomegalovirus Infections/prevention & control , Drug Administration Schedule , Drug Therapy, Combination , Female , Ganciclovir/administration & dosage , Ganciclovir/analogs & derivatives , Graft Survival , Greece/epidemiology , Humans , Immunosuppressive Agents/adverse effects , Incidence , Kidney Transplantation/immunology , Kidney Transplantation/mortality , Linear Models , Living Donors , Male , Middle Aged , Multivariate Analysis , Prevalence , Retrospective Studies , Time Factors , Treatment Outcome , Valganciclovir , Viral Load
15.
Transplant Proc ; 44(9): 2718-20, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23146503

ABSTRACT

BACKGROUND: Renal transplantation represents the main treatment for end-stage renal disease. The goal of this study was to evaluate the course and outcome of renal transplant recipients admitted to the intensive care unit (ICU) and to analyze factors determining prognosis and mortality. METHODS: The demographic features, data admission characteristics, and ICU courses of all renal transplant recipients admitted to our ICU from 1992 to 2012 were evaluated to analyze factors for mortality. RESULTS: Eleven women and 50 men of mean age 45.5 ± 12.5 years were included in the study. Acute Physiology And Chronic Health Evaluation (APACHE II) and Sequential Organ Failure Assessment (SOFA) scores on ICU admission were 20 ± 5.7 and 8.5 ± 3.5, respectively. The main reasons for admission were as follows: sepsis (n = 27) or immediate postoperative complications (n = 16). Thirty-five patients during their ICU stay required hemodialysis and 34 needed catecholamines. The mortality rate was 42.6%. APACHE II Score, dialysis requirement, and sepsis as a reason for ICU admission were independently related to the mortality. CONCLUSIONS: The mortality rate was higher than that of the general ICU population (42.6% vs 30%). The main reason for ICU admission of renal transplant recipients was sepsis.


Subject(s)
Intensive Care Units , Kidney Transplantation/adverse effects , Patient Admission , Postoperative Complications/therapy , APACHE , Adult , Catecholamines/therapeutic use , Female , Hospital Mortality , Humans , Kidney Transplantation/mortality , Length of Stay , Logistic Models , Male , Middle Aged , Multivariate Analysis , Odds Ratio , Organ Dysfunction Scores , Postoperative Complications/diagnosis , Postoperative Complications/etiology , Postoperative Complications/mortality , Prospective Studies , Renal Dialysis , Respiration, Artificial , Retrospective Studies , Risk Factors , Sepsis/etiology , Sepsis/therapy , Time Factors , Treatment Outcome
16.
Transplant Proc ; 44(9): 2721-3, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23146504

ABSTRACT

INTRODUCTION: The aim of this study was to evaluate infection complications as the reason for intensive care unit (ICU) admission among transplant recipients. METHODS: We studied all renal transplant recipients with infectious complications admitted to our ICU from 1992 to 2012:44.3% of all renal transplant recipients admitted to ICU. The epidemiology and prognosis of infectious complications requiring ICU admission were evaluated with analysis of mortality factors. RESULTS: The 22 men and 5 women included in this study showed a mean age of 42.7 ± 12.3 years. The Acute Physiologic and Chronic Health Evaluation II and Seguential Organ Failure Assessment scores on ICU admission were 20 ± 4.6 and 8.6 ± 3.9, respectively. The main infections complications requiring ICU admission were cytomegalovirus pneumonia (n = 15) and aspergillus pneumonia (n = 4). Sixteen patients required hemodialysis and 14, catecholamine support upon ICU admission owing to septic shock. The mortality rate among study patients was 62.9%, versus 26.5% for noninfectious renal transplant recipients requiring ICU admissions. Catecholamine support at ICU admission was independently related to mortality. CONCLUSION: The mortality rate of renal transplant recipients admitted to ICU owing infection complications was higher than that of noninfected renal transplant patients. These data suggest that infections and septic shock in renal transplant recipients requiring ICU admission worsen their outcome significantly.


Subject(s)
Communicable Diseases/therapy , Intensive Care Units , Kidney Transplantation/adverse effects , Patient Admission , APACHE , Adult , Catecholamines , Communicable Diseases/diagnosis , Communicable Diseases/etiology , Communicable Diseases/mortality , Female , Hospital Mortality , Humans , Kidney Transplantation/mortality , Length of Stay , Logistic Models , Male , Middle Aged , Multivariate Analysis , Organ Dysfunction Scores , Prospective Studies , Renal Dialysis , Respiration, Artificial , Retrospective Studies , Risk Factors , Shock, Septic/etiology , Shock, Septic/therapy , Time Factors , Treatment Outcome
17.
Transplant Proc ; 44(9): 2724-6, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23146505

ABSTRACT

Predicting the prognosis of cirrhotic patients is considered to achieve a fair allocation among patients awaiting orthotopic liver transplantation (OLT). Serum sodium (Na) concentrations are associated with reduced survival among patients with cirrhosis. The mortality risk of cirrhotic patients, as defined by the Model for End-Stage Liver Disease (MELD) score, is considered to be higher in hyponatremic patients. The aim of this study was to record complications and outcomes of severely hyponatremic patients after OLT. We retrospectively studied 75 recipients of OLT over the last 3 years. Hyponatremic patients showed lower 30-day and intensive care unit (ICU) survivals (P = .022 and .028, respectively), higher rates of neurological complications (P = .038), renal failure (P = .001), and prolonged duration of mechanical ventilation (P = .000) and ICU stay (P = .000). Severe hyponatremia was related to a greater risk for neurological and renal complications after OLT.


Subject(s)
Hyponatremia/complications , Liver Cirrhosis/surgery , Liver Transplantation/adverse effects , Nervous System Diseases/etiology , Renal Insufficiency/etiology , Biomarkers/blood , Chi-Square Distribution , Humans , Hyponatremia/blood , Hyponatremia/diagnosis , Hyponatremia/mortality , Intensive Care Units , Kaplan-Meier Estimate , Length of Stay , Liver Cirrhosis/etiology , Liver Cirrhosis/mortality , Liver Transplantation/mortality , Nervous System Diseases/mortality , Nervous System Diseases/therapy , Odds Ratio , Renal Insufficiency/mortality , Renal Insufficiency/therapy , Respiration, Artificial , Retrospective Studies , Risk Factors , Severity of Illness Index , Sodium/blood , Time Factors , Treatment Outcome
18.
Transplant Proc ; 44(9): 2741-4, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23146510

ABSTRACT

Hepatic artery thrombosis (HAT), a serious complication after orthotopic liver transplantation (OLT), can lead to patient death in the absence of revascularization or retransplantation. Herein we have presented clinical characteristics, imaging findings, and long-term outcomes of 3 OLT patients with HAT who were treated conservatively and developed hepatic arterial collaterals. These patients underwent transplantation due to hepatitis B cirrhosis, cryptogenic cirrhosis, or hepatitis C infection and alcoholic disease. They presented with bile duct stenosis and/or a bile leak at 1, 3, and 36 months after transplantation, respectively, and were treated with percutaneous drainage and stent placement, endoscopic retrograde cholangio-pancreatography (ERCP), or reanastomosis of the bile duct over a T tube. HAT was confirmed using multidetector computed tomography (MDCT) 3-dimensional (3D) angiography and Doppler sonography. They survive in good condition with normal liver function at 30, 50, and 42 months after OLT, respectively. Development of collateral arterial circulation to the liver graft was detected with MDCT 3D angiography and Doppler sonography. From our experience with 3 patients and a literature review, we believe that there are a number of patients who experience long-term survival after the diagnosis of irreversible HAT and the development of collaterals. Although this group is at high risk for sepsis and biliary complications, these are usually self-limiting complications due to improved treatment regimens. The development of collateral arterial flow may also be beneficial.


Subject(s)
Arterial Occlusive Diseases/etiology , Collateral Circulation , Hepatic Artery/physiopathology , Liver Circulation , Liver Transplantation/adverse effects , Thrombosis/etiology , Adult , Aged , Anastomotic Leak/etiology , Anastomotic Leak/therapy , Arterial Occlusive Diseases/diagnosis , Arterial Occlusive Diseases/physiopathology , Arterial Occlusive Diseases/therapy , Cholestasis/etiology , Cholestasis/therapy , Hepatic Artery/diagnostic imaging , Humans , Male , Middle Aged , Multidetector Computed Tomography , Thrombosis/diagnosis , Thrombosis/physiopathology , Thrombosis/therapy , Time Factors , Treatment Outcome , Ultrasonography, Doppler
19.
Transplant Proc ; 44(9): 2748-50, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23146512

ABSTRACT

PURPOSE: The purpose of the study was to assess the characteristics and risk factors of infections in the early period after orthopic liver transplantation (OLT) among adult patients. MATERIAL AND METHODS: We studied 75 patients who underwent OLT over 3 years from 2008 to 2010. We recorded all infections that developed during hospitalization in the intensive care unit (ICU) their outcomes, and the possible risk factors. RESULTS: During the study period in 80 OLT we recorded 19 bloodstream infections (47.5%), 7 ventilator-associated pneumonias (VAP; 17.5%), and 14 intra-abdominal infections (35%). Among the 40 isolated microbes, 72.5% were Gram negative, 25% were Gram positive, and 2.5% were fungi. The median time to developing the infection was 4.95 days (range 2-10). Patients with infections showed longer durations of mechanical ventilation, longer lengths of ICU stay, and lower 1-year survivals.


Subject(s)
Bacterial Infections/epidemiology , Intensive Care Units , Liver Transplantation/adverse effects , Adult , Bacterial Infections/diagnosis , Bacterial Infections/microbiology , Bacterial Infections/mortality , Bacterial Infections/therapy , Chi-Square Distribution , Female , Greece/epidemiology , Humans , Incidence , Kaplan-Meier Estimate , Length of Stay , Liver Transplantation/mortality , Male , Middle Aged , Odds Ratio , Prognosis , Respiration, Artificial , Risk Factors , Time Factors
20.
Transplant Proc ; 44(9): 2751-3, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23146513

ABSTRACT

BACKGROUND: Liver transplantation is the treatment of choice for patients with end-stage liver disease; however, it is associated with a multitude of postoperative complications. Herein we have presented our experience with the application of multidetector computed tomography (MDCT) in the follow-up of liver transplant recipients. PATIENTS AND METHODS: Twenty-four liver transplantation patients were examined with triphasic hepatic computed tomography. Both symptomatic and asymptomatic patients were included in the study. Examinations were performed using a multidetector scanner. RESULTS: We documented seven cases of thrombosis, three stenosis, and two hepatic artery (HA) aneurysms. Portal vein (PV) stenosis and PV thrombosis were observed in two cases each. We observed one case of synchronous HA and PV stenosis; one inferior vena cava (IVC) and left renal vein thrombosis, and one IVC thrombosis. In three cases of HA obstruction we observed transplant neovascularization. One HA obstruction and one HA stenosis were accompanied by bilomas. Finally, we discovered three cases of hepatocellular carcinoma. CONCLUSION: In our experience MDCT as a single noninvasive examination, was a sensitive means to detect and evaluate vascular complications after liver transplantation, offering adequate information concerning the liver parenchyma, the rest of the abdomen, and to a lesser extent the biliary tract.


Subject(s)
Bile Duct Diseases/diagnostic imaging , Carcinoma, Hepatocellular/diagnostic imaging , Liver Neoplasms/diagnostic imaging , Liver Transplantation/adverse effects , Multidetector Computed Tomography , Phlebography/methods , Vascular Diseases/diagnostic imaging , Aneurysm/diagnostic imaging , Aneurysm/etiology , Arterial Occlusive Diseases/diagnostic imaging , Arterial Occlusive Diseases/etiology , Bile Duct Diseases/etiology , Carcinoma, Hepatocellular/etiology , Constriction, Pathologic , Hepatic Artery/diagnostic imaging , Humans , Liver Neoplasms/etiology , Portal Vein/diagnostic imaging , Predictive Value of Tests , Renal Veins/diagnostic imaging , Vascular Diseases/etiology , Vena Cava, Inferior/diagnostic imaging , Venous Thrombosis/diagnostic imaging , Venous Thrombosis/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...